Xuepei Zhang

1.4k total citations
70 papers, 778 citations indexed

About

Xuepei Zhang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Xuepei Zhang has authored 70 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 20 papers in Molecular Biology. Recurrent topics in Xuepei Zhang's work include Renal cell carcinoma treatment (12 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Prostate Cancer Treatment and Research (9 papers). Xuepei Zhang is often cited by papers focused on Renal cell carcinoma treatment (12 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Prostate Cancer Treatment and Research (9 papers). Xuepei Zhang collaborates with scholars based in China, Sweden and France. Xuepei Zhang's co-authors include Yonghao Zhan, Lianghao Zhang, Biao Dong, Shuanbao Yu, Zhaowei Zhu, Jinxing Wei, Jian‐Ge Wang, Dongkui Song, Yanfeng Yang and Dong Fang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Xuepei Zhang

68 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuepei Zhang China 17 357 225 198 163 110 70 778
Yucong Zhang China 18 239 0.7× 95 0.4× 379 1.9× 143 0.9× 206 1.9× 100 966
Yu Fan China 21 705 2.0× 349 1.6× 444 2.2× 244 1.5× 169 1.5× 102 1.5k
Keita Sakamoto Japan 16 255 0.7× 147 0.7× 127 0.6× 132 0.8× 171 1.6× 49 773
Xuefeng Xu China 17 266 0.7× 92 0.4× 303 1.5× 108 0.7× 118 1.1× 55 882
Donghui Han China 19 422 1.2× 160 0.7× 284 1.4× 62 0.4× 210 1.9× 56 1.1k
Vincent Crenn France 14 230 0.6× 165 0.7× 213 1.1× 219 1.3× 152 1.4× 71 990
Michael Abend Germany 25 585 1.6× 420 1.9× 418 2.1× 133 0.8× 206 1.9× 114 1.6k
Masayoshi Yamamoto Japan 17 149 0.4× 99 0.4× 203 1.0× 164 1.0× 215 2.0× 64 815
Dedong Ma China 15 218 0.6× 80 0.4× 171 0.9× 90 0.6× 144 1.3× 46 767

Countries citing papers authored by Xuepei Zhang

Since Specialization
Citations

This map shows the geographic impact of Xuepei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuepei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuepei Zhang more than expected).

Fields of papers citing papers by Xuepei Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuepei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuepei Zhang. The network helps show where Xuepei Zhang may publish in the future.

Co-authorship network of co-authors of Xuepei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuepei Zhang. A scholar is included among the top collaborators of Xuepei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuepei Zhang. Xuepei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yuanhao, Sheng Liu, Yiheng Dai, et al.. (2025). ACSL5 regulated acetyl-CoA to promote bladder cancer cellular senescence via 53BP1 acetylation. Oncogene. 44(34). 3096–3112. 1 indexed citations
2.
Wang, Shengzheng, et al.. (2025). Robot-assisted Single-docking Approach for Level III Inferior Vena Cava Tumor Thrombectomy: Surgical Technique and Outcomes. European Urology. 88(2). 204–211. 1 indexed citations
3.
Pokhrel, Gaurab, Bo Jin, Yonghao Zhan, et al.. (2025). Initial experience with the novel modular robotic system Carina in urology: a prospective study on safety feasibility and surgical settings. Scientific Reports. 15(1). 12686–12686. 1 indexed citations
4.
Zhan, Yonghao, Zhaowei Zhu, Lianghao Zhang, et al.. (2025). Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2. Journal of Experimental & Clinical Cancer Research. 44(1). 80–80. 7 indexed citations
5.
Wang, Shengzheng, et al.. (2024). Impact of Left Renal Vein Ligation on Renal Function Following En Bloc Resection of Segmental Inferior Vena Cava and Right Kidney. Annals of Surgical Oncology. 31(7). 4787–4794. 2 indexed citations
6.
Yu, Shuanbao, Yang Yang, Zeyuan Wang, et al.. (2024). CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesions. Cancer Imaging. 24(1). 130–130. 3 indexed citations
7.
8.
Wang, Shengzheng, et al.. (2024). ASO Author Reflections: The Impact of Left Renal Vein Dissection on Renal Function in a Solitary Kidney. Annals of Surgical Oncology. 31(8). 5473–5474.
9.
Gao, Yu, Yang Yang, Shaoxi Niu, et al.. (2024). Suitability of the MP1000 system for robot-assisted partial nephrectomy: a multicenter randomized controlled noninferiority trial. International Journal of Surgery. 110(5). 2803–2809. 7 indexed citations
10.
Feng, Jinjin, Jianguo Wen, Yanping Zhang, et al.. (2022). Erythropoietin prevented the decreased expression of aquaporin1–3 in ureteral obstructive kidneys in juvenile rats. Pediatric Research. 93(5). 1258–1266. 1 indexed citations
11.
Ye, Dingwei, Xiaojie Bian, Bin Wu, et al.. (2022). Phase II therapeutic equivalence study of Abiraterone Acetate Tablets (I) vs. ZYTIGA® in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 40(16_suppl). e17040–e17040.
12.
Qu, Yuanyuan, Qing Zou, Hongqian Guo, et al.. (2021). Camrelizumab plus famitinib for advanced renal cell carcinoma or unresectable urothelial carcinoma: Updated results from a phase II trial.. Journal of Clinical Oncology. 39(15_suppl). 4550–4550. 2 indexed citations
13.
Yu, Shuanbao, et al.. (2021). Evaluating Incidence, Location, and Predictors of Positive Surgical Margin Among Chinese Men Undergoing Robot-Assisted Radical Prostatectomy. Cancer Control. 28. 2895473313–2895473313. 7 indexed citations
14.
Wang, Jin, Xuepei Zhang, San‐Qi Zhang, et al.. (2020). Novel PI3K/Akt/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy. International Journal of Oncology. 58(1). 70–82. 28 indexed citations
15.
Liu, Junxiao, Biao Dong, Jian‐Ge Wang, et al.. (2020). Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone. Scientific Reports. 10(1). 5157–5157. 34 indexed citations
16.
Guo, Lijuan, Zhaowei Zhu, & Xuepei Zhang. (2020). Adding radiotherapy to androgen deprivation therapy in men with node-positive prostate cancer after radical prostatectomy. Medicine. 99(10). e19153–e19153. 4 indexed citations
17.
Zhan, Yonghao, Lianghao Zhang, Shuanbao Yu, et al.. (2020). Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 136–136. 33 indexed citations
18.
Zhu, Zhaowei, et al.. (2019). Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A meta-analysis. PLoS ONE. 14(9). e0222223–e0222223. 17 indexed citations
19.
Wang, Shengzheng, et al.. (2017). Retroperitoneal laparoscopic extravascular stent placement for nutcracker syndrome. Zhonghua miniao waike zazhi. 38(3). 174–177. 1 indexed citations
20.
Zhang, Xiaoming, et al.. (2006). Effect of forest vegetation on runoff and sediment production in sloping lands of Loess area. Frontiers of Forestry in China. 1(3). 336–342. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yucong Zhang Breakdown of academic impact, for papers by Yu Fan Breakdown of academic impact, for papers by Keita Sakamoto Breakdown of academic impact, for papers by Xuefeng Xu Breakdown of academic impact, for papers by Donghui Han Breakdown of academic impact, for papers by Vincent Crenn Breakdown of academic impact, for papers by Michael Abend Breakdown of academic impact, for papers by Masayoshi Yamamoto Breakdown of academic impact, for papers by Dedong Ma
Rankless by CCL
2026